<VariationArchive RecordType="classified" VariationID="10457" VariationName="NG_011977.2:g.?_(146097_162513)del" VariationType="Deletion" Accession="VCV000010457" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2019-02-04" MostRecentSubmission="2019-02-04">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="25496" VariationID="10457">
      <GeneList>
        <Gene Symbol="COL4A5" FullName="collagen type IV alpha 5 chain" GeneID="1287" HGNC_ID="HGNC:2207" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xq22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="108439838" stop="108697545" display_start="108439838" display_stop="108697545" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="107683073" stop="107940774" display_start="107683073" display_stop="107940774" Strand="+" />
          </Location>
          <OMIM>303630</OMIM>
          <Haploinsufficiency last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-09-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=COL4A5">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NG_011977.2:g.?_(146097_162513)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq22.3</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>38-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_232" sequenceAccession="LRG_232">
            <Expression>LRG_232:g.?_(146097_162513)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011977.2" sequenceAccession="NG_011977" sequenceVersion="2" change="g.?_(146097_162513)del">
            <Expression>NG_011977.2:g.?_(146097_162513)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.?_(108581020_108597436)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.?_(108581020_108597436)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="303630.0005" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided HGVS expressions for allelic variant 303630.0005 based on this statement in the paper by Renieri et al., 1992 (PubMed 1577459): "...3' boundary could be traced within segment A718, i.e., between the EcoRI site at nucleotide 687 and the
EcoRV site at 1405 in the published cDNA sequence (Pihlajaniemi et al. 1990)."  The accession of this sequence is M58526.1.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_011977.2:g.?_(146097_162513)del AND X-linked Alport syndrome" Accession="RCV000011203" Version="6">
        <ClassifiedConditionList TraitSetID="2968">
          <ClassifiedCondition DB="MedGen" ID="C4746986">X-linked Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1992-04-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1992-04-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-02-04" MostRecentSubmission="2019-02-04">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1577459</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2968" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="220" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">X-linked Alport syndrome</ElementValue>
                <XRef ID="MONDO:0010520" DB="MONDO" />
                <XRef ID="88917" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alport syndrome 1, X-linked recessive</ElementValue>
                <XRef ID="Alport+Syndrome/335" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEPHROPATHY AND DEAFNESS, X-LINKED</ElementValue>
                <XRef Type="MIM" ID="301050" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alport Syndrome and Thin Basement Membrane Nephropathy</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XLAS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ATS</ElementValue>
                <XRef ID="GTR000525320" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="301050" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ATS1</ElementValue>
                <XRef Type="MIM" ID="301050" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">COL4A5-Related Nephropathy</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5785" />
                <XRef ID="5785" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88917" DB="Orphanet" />
              <XRef ID="C4746986" DB="MedGen" />
              <XRef ID="MONDO:0010520" DB="MONDO" />
              <XRef Type="MIM" ID="301050" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="31430" SubmissionDate="2019-01-31" DateLastUpdated="2019-02-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="303630.0005_ALPORT SYNDROME 1, X-LINKED" title="COL4A5, 38-KB DEL_ALPORT SYNDROME 1, X-LINKED" />
        <ClinVarAccession Accession="SCV000031430" DateUpdated="2019-02-04" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1992-04-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 12-year-old Italian boy with Alport syndrome (ALS1; 301050), Renieri et al. (1992) found a large deletion (more than 38 kb) that included the 5-prime part of the COL4A5 gene.</Attribute>
              <Citation>
                <ID Source="PubMed">1577459</ID>
              </Citation>
              <XRef DB="OMIM" ID="301050" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A5" />
          </GeneList>
          <Name>COL4A5, 38-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">38-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="303630.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALPORT SYNDROME 1, X-LINKED</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="31430" TraitType="Disease" MappingType="Name" MappingValue="ALPORT SYNDROME 1, X-LINKED" MappingRef="Preferred">
        <MedGen CUI="C4746986" Name="X-linked Alport syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

